LON:CIR Circassia Group (CIR) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Circassia Group Stock (LON:CIR) 30 days 90 days 365 days Advanced Chart Get Circassia Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range 34▼ 3452-Week Range N/AVolume4,513 shsAverage Volume773,465 shsMarket Capitalization£142.66 millionP/E Ratio3,400.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCircassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.Read More… Receive CIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CIR Stock News HeadlinesPrivate equity firm withdraws takeover bid for NIOX GroupApril 11, 2025 | msn.comNiox Group PLC (NIOX)April 10, 2025 | uk.investing.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 20, 2025 | American Alternative (Ad)Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsightAugust 8, 2024 | finance.yahoo.comAllergy Shot Market Revenue Estimated to Grow at 6.1% CAGR to Reach US$ 3.34 Billion by 2034: Fact.MR ReportJuly 19, 2024 | finance.yahoo.comBTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled AsthmaMay 24, 2024 | msn.comBorder guards capture Russian soldier disguised in Ukrainian uniform in Donetsk Oblast – VideoMay 24, 2024 | msn.comCathie Wood buys $40 million of wounded tech stockMay 3, 2024 | thestreet.comSee More Headlines CIR Stock Analysis - Frequently Asked Questions How were Circassia Group's earnings last quarter? Circassia Group Plc (LON:CIR) posted its earnings results on Thursday, September, 17th. The company reported ($3.00) earnings per share (EPS) for the quarter. How do I buy shares of Circassia Group? Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Circassia Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), Tullow Oil (TLW), Ascential (ASCL), FutureFuel (FF) and H&T Group (HAT). Company Calendar Last Earnings9/17/2020Today4/20/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:CIR CIKN/A Webwww.circassia.co.uk Phone44 1865 405 560FaxN/AEmployees111Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio3,400.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.95 Current Ratio1.83 Quick Ratio1.50 Sales & Book Value Annual Sales£27.90 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow11.33 Book ValueGBX 16 per share Price / BookN/AMiscellaneous Outstanding Shares419,578,000Free FloatN/AMarket Cap£142.66 million OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (LON:CIR) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Circassia Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Circassia Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.